John Cataldi currently directs the investment activities and fund strategies of the NAVF-Pharma Family (NAVF-Pharma). NAVF-Pharma is a series of impact investment funds that promote Environmental, Social and Governance (ESG) development activities for indigenous tribes throughout North America.

Under Cataldi’s leadership, the fund leverages special contracting preferences, tax incentives, and other distinct competitive advantages legislatively granted to federally recognized tribes. NAVF-Pharma’s portfolio focuses across multiple industries to include Carbon Sequestration, Pharmaceutical importation/distribution, FinTech, E-Commerce and Government Contracting. As the previous COO of the Seminole Tribe of Florida, Inc., Cataldi managed 47 businesses, to include, new merger and acquisition activities. STOFI’s business portfolio included construction, CPG, energy/petroleum, pharmaceuticals, Hard Rock Energy Drink, financial services, agriculture, restaurant/hospitality, gaming and enterprise technology. In addition, Cataldi co-authored, with NAVF-Pharma’s Partner / CFO, Brent Hill, various tribal legislation and economic development opportunities that generated in excess of $1B in new revenues and a $150-200M+ per annum via an IRS approved tribal tax exemption.

Cataldi served six years in the US Army Reserve and the Georgia National Guard, has been published, as lead author, with peer review for his cancer research in partnership with the National Institutes of Health (NIH), graduated from the University of West Georgia with advanced studies in Biology, Chemistry and Physics and is currently in pursuit of his Juris Doctorate (J.D.) degree. Cataldi serves as an active member of multiple service organizations, most notable is the Business Executives for National Security (BENS).